4D Molecular Therapeutics (FDMT) Earnings Date & Reports
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FDMT is expected to report earnings to rise 3.06% to -100 cents per share on November 05
Q3'25
Est.
$-1.01
Q2'25
Missed
by $0.25
Q1'25
Est.
$-0.86
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.11
The last earnings report on August 11 showed earnings per share of -98 cents, missing the estimate of -73 cents. With 176.56K shares outstanding, the current market capitalization sits at 306.84M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FDMT showed earnings on August 11, 2025. You can read more about the earnings report here.